Plus, a small-cap favorite reopens, changes at Oak Value, and more.
Diversified foreign-stock funds with ample emerging-markets exposure offer a great entry point into developing regions.
Industry dynamics are shifting in the wake of Zimmer's Biomet acquisition.
A clear view of the present is the only thing that Richard Bregman thinks can guide his investment decisions.
Stock returns since October 2007 have been flat, but these funds have been anything but.